HDAC9 and lymphoma: In fact, another class IIa HDAC, HDAC4, has been reported to be a target of miR-155 in a Eu-miR-155 transgenic mouse model.36 Eu-miR-155 mice exhibit high proliferation rates of pre-B cells and develop lymphoma/leukemia.